Gammalinolenic acid treatment of fatigue associated with primary Sjögren's syndrome.
Objective: To evaluate the eYcacy of the essential omega-6 fatty acid Gammalinolenic acid (GLA) on fatigue associated with primary Sjo¨ gren’s syndrome. Methods: Ninety patients with primary Sjo¨ gren’s syndrome (with or without signs of autoimmunity) entered a 6-month double blind placebo-controlled randomised trial with high dose GLA (extracted from Evening Primrose Oil ) or corn oil. The primar
